Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PharmaMar logo — Innovative Oncology

PharmaMar

Innovative Oncology

Founded 1986 Spain Spain 447 employees Biotechnology, Health Care +1

General Information

Company Name PharmaMar
Founded Year 1986
Location Spain Spain +1
Founders / Decision Makers
Team member
Employees 447
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when PharmaMar moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PharmaMar

PharmaMar is a Madrid-based biopharmaceutical company with a focus on oncology, known for its commitment to research and development inspired by the sea to discover molecules with antitumor activity. The company is dedicated to providing healthcare professionals with innovative products to treat cancer. With a foundation established in 1986, PharmaMar has become one of the world leaders in the discovery of antitumor drugs of marine origin. The company has a pipeline of drug candidates and a robust R&D oncology program, including the development and commercialization of Yondelis® in Europe, as well as other clinical-stage programs under development for several types of solid cancers: lurbinectedin (PM1183), PM184, and PM14. PharmaMar also has subsidiaries in Germany, Italy, France, Switzerland, Belgium, Austria and the United States, along with full ownership of companies such as GENOMICA, a molecular diagnostics company, and Sylentis, dedicated to researching therapeutic applications of gene silencing (RNAi). For more information about PharmaMar, please visit www.pharmamar.com.

Taxonomy: oncology, biopharmaceutical, drug discovery, drug development, molecular diagnostics, gene silencing, clinical-stage programs, antitumor drugs, cancer treatment, pharmaceutical marketing

No funding data available for PharmaMar yet.

Get notified when PharmaMar raises funding

PharmaMar Alternatives & Competitors

PharmaMar vs
CytRx
CytRx

Driving Oncology Innovation with Advanced Chemotherapeutic Solutions

Post Ipo Equity
Biopharma, Biotechnology
PharmaMar vs
Sumitomo Pharma Oncology
Sumitomo Pharma Oncology United States

is part of Sumitomo Pharma America as of July 2023

49 employees
Health Care, Health and Wellness
PharmaMar vs
TCD Pharma
TCD Pharma

Chosen as one of Spain’s top 5 biotech investment opportunities, TCD is focused on creating the futu...

Series B
2 employees
Biotechnology

FAQ About PharmaMar

Innovative Oncology
PharmaMar was founded in 1986.
PharmaMar is headquartered in Spain.
PharmaMar operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
PharmaMar has approximately 447 employees.
Top alternatives and competitors to PharmaMar include CytRx, Sumitomo Pharma Oncology, TCD Pharma, Astex Pharmaceuticals , Automera. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmaMar and CytRx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PharmaMar and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy